MarketsandMarkets is proud to announce the 4th Annual MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference to be held on 22- 23 April, 2021.

While the 3rd annual virtual conference had discussions on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers, the 4th Annual conference will focus on discussion about the application of RWD/RWE across the life cycle. The event will discuss Impact of COVID-19 on the real-world generation and making sense of the Electronic Health Records data for COVID-19.

5G is paving the way in many smart opportunities and is revolutionizing the technology world. Breakthrough technologies for the 5G deployment and infrastructure are going to change the game.

The conference is focused on few of the major questions such as what is the Influence of ML and AI on 5G? The privacy and security risk? How to tap into 5G monetization opportunity? Understanding business implications of booming trends of 5G

Digitization, growing robotics, and modern business models have revolutionized most sectors, especially the automotive industry. Linked cars with automatic piloting have forced the digitalisation of the automotive industry, showing the undeniable value of data in automotive market.

Growing interest in 3D printing in the automotive industry, starting from the possibility of fast prototyping, this technology is proving vital role in the industry.

After the successful foureditions of Bioprocessing of Cell therapies, coming up with 5th Annual of Bioprocessing of Biotherapeutics brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development, manufacture and quality of protein expressions, cell, and gene therapies.

The virtual event will present detailed case studies and interactive discussions in cell culture, scale-up, continuous processing, recovery, purification, process and product characterization, and formulation.

Technology and creativity continue to alter the working environment. Consumer demands are becoming more challenging every day, and keeping up with trends can be overwhelming. Today's leadership of the CMO is about promoting growth, and their responsibility for sales and marketing strategies that needed to meet business acumen is utmost challenging

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our MarketsandMarkets 3rd Annual Cell & Gene Therapy Manufacturing Virtual Conference Cell culture & Bioprocessing.
 

Pharmaceutical supply chain and logistics faced the hardest disruptions during initial COVID era. Now, with COVID therapeutic manufacturing taking priority, there also is a big desire to accelerate other clinical pipeline because of the ample opportunity for new medicine. While some companies were able to cope with their contingencies plan in place, the other followed risk mitigation. It is now essential for the pharma supply chain and logistics to follow the redundancy routes.  

Various laboratory automation software solutions are expected to offer lucrative growth opportunities such as lab information management solutions is poised to grow at 2X the analytical tech industry during 2021-2025; driven by numerous engines such as rising research expenditure of pharma-biotech cos, stringent compliance to quality control regulations by drug manufacturing and applied industries, expansion & modernization of healthcare infrastructure across emerging markets, and greater utilization of integrated lab platforms globally

From automated platforms and integrated platforms improving overall operational efficiency to data management & AI-driven analytical solutions that help customers with improved lab outcomes, the laboratory automation will continue to evolve and provide a host of attractive, high growth opportunities

Participants such as CIOs, CTOs, CMOs, automation platform providers, digital solution and service providers, automation technology providers etc can benefit from this unprecedented growth over the next 5 years

This Crystal Ball event focuses on learning more about the most promising opportunities in the lab automation space, as seen through the lens of eminent CXOs in this space

The digital health market is expected to grow at over ~28% CAGR to be close to ~350 billion market in 2025. Numerous engines are expected to fuel its growth – telehealth and telemedicine, mHealth, Digital Therapeutics, cloud computing, Healthcare IoT, wearable technologies, virtual assistants, Augmented and virtual reality as well as others.

A host of attractive, high growth opportunities such as Artificial Intelligence and analytics, Precision medicine,  patient engagement, remote patient monitoring, 5G, Automation, Medical Robots, Healthcare 4.0 etc could be pursued. Participants such as Network connectivity and hardware providers, OEMs, infrastructure service providers, Software, Platform and service vendors, medical device manufacturers, system integrators, hospital and health systems, Health insurance payers, Pharmaceutical and biotechnology companies etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the digital health ecosystem, as seen through the lens of eminent CXOs in this space.

Organizations must make consumer service the starting point for product creation to satisfy consumer’s ever-changing needs. Learning and using human-centred approaches in a creative manner will help to solve business challenges in BFSI industry. Innovation in Business strategies by incorporating a structured design thinking format with empathy at its core is the most important aspect in today’s world for business growth. Explore new business ideas with a human centered design strategy at 2nd Edition MarketsandMarkets Design Thinking – BFSI Virtual Summit, scheduled to be held on 16th-17th June. Join us for a two-day virtual conference where business leaders will share their perspectives and insights that have enabled their organization's development and profitability. 

The smart manufacturing market are expected to reach USD 384 billion market in 2025. Numerous enabling technology are expected to fuel its growth – Condition Monitoring, Artificial Intelligence, Digital Twin, Industrial 3D Printing, Collaborative Robots, Industrial Cybersecurity, Warehouse Management Systems, Manufacturing Execution System and Automated Guided Vehicle. 

A host of attractive, high growth opportunities such as IoT in Manufacturing, AR/VR in Manufacturing, Industrial Robotics, Blockchain in Manufacturing, Warehouse Robotics & Automation, and 5G Infrastructure could be pursued. Participants such as technology providers, machine/equipment providers, Software & ICT players, System Integrator, and end user industry can be benefited from this unprecedented growth over the next 5 years  

This Crystal Ball event focuses on learning more about the most promising opportunities in the Smart Manufacturing ecosystem, as seen through the lens of eminent CXOs in this space.

The AR market is expected to grow to be a USD 77 billion market in 2025 driven by key use cases in healthcare, retail etc. Gaming and lifestyle are prominent AR apps that are being downloaded by numerous users. Gaming contributes to about 25% of the total AR app downloads, while lifestyle contributes ~20%.

The VR market is expected to reach USD 21 billion by 2025 at a CAGR of ~28% from 2020 to 2025. Due to the increasing demand for hardware devices, the VR market has witnessed high growth. The VR content creation market is expected to witness growth driven by the inflow of content to fulfil the requirements of different applications using VR HMDs. This will be a massive boost to the growth of the VR market.

This Crystal Ball event focuses on learning more about the most promising opportunities in the AR/VR ecosystem, as seen through the lens of eminent CXOs in this space.

•The 3D printing  market are expected to grow at over 18% to be a $30 billion market in 2025. Numerous engines are expected to fuel its growth – Digital Manufacturing, Industrial Internet of Things (IIOT)x, Industrial 3D Printing, Automated 3D Printing, 3D food Printing, 3D Mapping and Modelling, Continuous Composites, 3D Print Robots, Metamaterials, 3D Metal Printing. 3D printing has gone through a revolution over the last 5 to 10 years. Though it is a consumer-oriented technology, it has evolved into a viable industrial manufacturing solution. The market map consists of various providers in the 3D ecosystem, namely, 3D printers, software, services, and material providers, along with research institutes.

A host of attractive, high growth opportunities such as Smart Factory, Rapid Prototyping, Continuous Composite, 4D Printing, AI & Machine Learning, 3D printing  in  IOT/Industry 4.0 etc could be pursued. Participants such as 3D Printers Manufacturer, OEMs, Software and Service Vendors, Material and Metal Machine providers etc can benefit from this unprecedented growth over the next 5 years.

•This Crystal Ball event focuses on learning more about the most promising opportunities in the 3D Printing  ecosystem, as seen through the lens of eminent CXOs in this space.

Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress-US Edition to be held on 28th-30th June 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

With an increasing amount of data, it has become vital for organizations to incorporate Big Data Analytics into their business processes. The continuous evolution Big Data Tools & Technologies has led to increase in its presence in day-to-day operations of several industries. The market holds enormous number of opportunities as well as challenges and it has become essential to keep track of these and incorporate them into our data strategy. The event focuses on Addressing the data quality issues, Big Data architectures to be incorporated for efficient and effective processes, Tools & Technologies that is uplifting the market and building an effective Testing Environment.

Technological innovation influences mission-critical applications in business processes and the manufacturing and technology companies that take the risk and are early adopters of new technology will be rewarded for their progressive decision-making. Since, digitization helps to ensure product quality and safety, as well as faster service delivery, it ensures to go a long way with customers. This has made the IoT adaptation the need of hour!
 

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

Our 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 26th - 29th October,2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.